ENTRY       D11061                      Drug
NAME        Osilodrostat (USAN/INN)
FORMULA     C13H10FN3
EXACT_MASS  227.0859
MOL_WEIGHT  227.237
CLASS       Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
REMARK      ATC code: H02CA02
            Chemical structure group: DG02839
            Product (DG02839): D11062<JP/US>
EFFICACY    Antihypertensive, Steroid 11-beta-hydroxylase inhibitor
COMMENT     Treatment of Cushing's syndrome
TARGET      CYP11B2 [HSA:1585] [KO:K07433]
  PATHWAY   hsa00140(1585)  Steroid hormone biosynthesis
            hsa04925(1585)  Aldosterone synthesis and secretion
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2B6 [HSA:1555], CYP2D6 [HSA:1565], UGT [KO:K00699]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02C ANTIADRENAL PREPARATIONS
                H02CA Anticorticosteroids
                 H02CA02 Osilodrostat
                  D11061  Osilodrostat (USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               DG02839  Osilodrostat
                D11061  Osilodrostat
              DG01644  CYP2D6 substrate
               DG02839  Osilodrostat
                D11061  Osilodrostat
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02839  Osilodrostat
                 D11061  Osilodrostat
              DG02924  UGT substrate
               DG02839  Osilodrostat
                D11061  Osilodrostat
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Cytochrome P450
                CYP11B2
                 D11061  Osilodrostat (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11061
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               DG02839  Osilodrostat
              DG01644  CYP2D6 substrate
               DG02839  Osilodrostat
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02839  Osilodrostat
              DG02924  UGT substrate
               DG02839  Osilodrostat
DBLINKS     CAS: 928134-65-0
            PubChem: 363669774
            PDB-CCD: YSY
ATOM        17
            1   C8x C    13.7900  -12.3200
            2   C8y C    13.7900  -13.7200
            3   C8y C    15.0024  -14.4200
            4   C8x C    16.2149  -13.7200
            5   C8x C    16.2149  -12.3200
            6   C8y C    15.0024  -11.6200
            7   C3b C    15.0024  -10.2202
            8   N3a N    15.0024   -8.8202
            9   X   F    12.5776  -14.4200
            10  C1y C    15.0024  -15.8198
            11  C1x C    13.8552  -16.6535
            12  C1x C    14.2936  -18.0023
            13  C8y C    15.7118  -18.0021
            14  N4y N    16.1499  -16.6533
            15  C8x C    16.8593  -18.8356
            16  N5x N    18.0065  -18.0018
            17  C8x C    17.5681  -16.6531
BOND        19
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     7   8 3
            9     2   9 1
            10   10   3 1 #Down
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15   10  14 1
            16   13  15 2
            17   15  16 1
            18   16  17 2
            19   14  17 1
///
